PRESCRIBING statins to
otherwise healthy patients is
probably unnecessary, according to
a Cochrane review published in the
UK this week.
The report concluded that statins
reduced overall death rates in the
population, but said there was no
evidence to justify the use of the
medications in people who are at
low risk of heart problems.The above article was sent to subscribers in Pharmacy Daily's issue from 20 Jan 11 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 20 Jan 11
STRONG growth in Australia has helped MedAdvisor Solutions achieve robust results for FY24, with a revenue increase of 24.6% on the previous corresponding period to $122.1 million.
WESFARMERS has today reported strong growth in revenue across its Health division and its Australian Pharmaceutical Industries (API) subsidiary, despite a significant reduction in COVID-19 anti-viral product sales.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.